Strategic Regulatory & Drug Development Consulting
From early drug development to marketing authorization, Ergomed Consulting minimizes regulatory risk. We offer tailored strategies for orphan drug designations, pediatric investigation plans (PIPs), and scientific advice meetings. Our global team ensures your submission strategy aligns with both US and European requirements for a smooth market entry.
Global Regulatory Expertise, Local Market Insight
At Ergomed Consulting, we bring a unique combination of global regulatory affairs consulting and local market insight to accelerate your clinical development.
With decades of experience in pharmaceutical regulatory consulting services, our team includes former FDA and EMA regulators, KOLs, and industry experts. This diverse regulatory and clinical expertise enables us to guide sponsors through complex international requirements while remaining aligned with evolving regional expectations.
Ergomed Consulting Services Include:
-
Our clinical development consultants support early strategic planning, indication prioritization, and gap analysis. By aligning clinical programs with regulatory expectations, we streamline pathways to trials and maximize early-stage success
-
Ergomed offers full clinical trial project management services, from protocol design to operational oversight. With proven expertise in outsourcing clinical research, we help sponsors scale efficiently without sacrificing quality or control.
-
Through targeted regulatory consulting, we provide clarity on IND/IMPD submissions, expedited pathways, and evolving compliance requirements.
-
Access to seasoned drug development consultants and KOLs ensures your program benefits from decades of therapeutic, operational, and statistical expertise.
-
Independent oversight that safeguards patients and ensures regulatory compliance.
-
Our consulting pharma services extend to RWD/RWE strategies that strengthen submissions, payer negotiations, and post-approval commitments.
Multidisciplinary Regulatory Expertise to Accelerate Success
Across every phase of the product lifecycle, Ergomed Consulting experts elevate your product viability–from shortened pathways to trial to regulatory agility and compliance, expedited global entry to sustained competitive edge. It’s what we do.
KOLs, Former Regulators, Expert Strategists
Complex Diseases and Novel Therapies
End-to-End Drug Development Advisory
Flexible Model and Bespoke Service
Global Perspective Combined with Local Insight
Ergomed Consulting Solutions
Ergomed Consulting delivers expert, customized regulatory consulting for clinical trials across the entire drug development lifecycle—from discovery and preclinical planning to regulatory submission and post-market management. With deep therapeutic knowledge, former regulators, and cross-functional CRO integration, we equip sponsors with the insight and support needed to move forward—confidently and compliantly—at every milestone.
Discovery & Preclinical Phase
In the early stages of drug development, companies often face significant challenges such as funding gaps, complex regulatory landscapes, and translational hurdles that can delay progress.
Clinical Research (Phases I–III)
Clinical development is often complicated by complex protocols, regulatory barriers, and fragmented market access strategies.
Market Application & Regulatory Review
During the market application and regulatory review phase, companies must navigate a complex regulatory framework, minimize the risk of submission delays, as well as disparate review and approval process.
Post-Market Safety & Lifecycle Management
Following market approval, evolving safety expectations, increasing demands for evidence generation, and lifecycle competition present ongoing challenges.
Strategic Pre-IND Consulting for Gene Therapy in Rare Leukemia
Early Stage Development in Rare Pediatric Oncology
Market Approval for a Novel Non-Hodgkin Lymphoma (NHL) Therapy
Post-Market Safety & Risk Management in Duchenne Muscular Dystrophy (DMD)
Team Member Spotlight:
Nan Shao, Executive Vice President of Ergomed Consulting
Our Executive Vice President of Ergomed Consulting, Nan Shao, brings over two decades of strategic and operational leadership in drug development. With a strong foundation as a trained statistician and extensive experience in both pharmaceutical and CRO settings, Nan has successfully led initiatives spanning the entire drug development lifecycle across diverse therapeutic areas.
Her expertise encompasses scientific rigor and operational excellence, empowering stakeholders through strategic use of data, optimized trial strategies, and patient-centric innovations. Nan is recognized for building collaborative, consultative partnerships that drive meaningful outcomes for clients and advance patient care.
In her role, Nan continues to shape the strategic direction of Ergomed Consulting by integrating data-driven insights, scientific innovation, and a steadfast commitment to improving healthcare outcomes.
Navigate the Complexities of the Entire Drug Development Path with Ergomed Consulting
At Ergomed Consulting, we simplify the complex with trusted regulatory consulting for clinical trials that spans the entire drug development lifecycle.
From early-stage planning to regulatory approval and post-market safety, our multidisciplinary team delivers integrated medical, scientific, statistical, and regulatory guidance tailored to your asset.
Whether you’re advancing a first-in-class therapy or refining a late-stage asset, our global regulatory affairs consulting helps you reduce risk, accelerate timelines, and bring safe, effective therapies to patients—worldwide.
Unparalleled Expertise,
Ergo, Flawless Execution
Contact Us
Our Complementary Services
See how Ergomed can support your clinical trial.
More Ergomed Services
Find out how Ergomed supports your clinical trial objectives.
Discover Our Latest Insights
Access Ergomed's resources for the latest in clinical trial trends and innovations.
Ergomed Consulting Services Include:
-
Our clinical development consultants support early strategic planning, indication prioritization, and gap analysis. By aligning clinical programs with regulatory expectations, we streamline pathways to trials and maximize early-stage success
-
Ergomed offers full clinical trial project management services, from protocol design to operational oversight. With proven expertise in outsourcing clinical research, we help sponsors scale efficiently without sacrificing quality or control.
-
Through targeted regulatory consulting, we provide clarity on IND/IMPD submissions, expedited pathways, and evolving compliance requirements.
-
Access to seasoned drug development consultants and KOLs ensures your program benefits from decades of therapeutic, operational, and statistical expertise.
-
Independent oversight that safeguards patients and ensures regulatory compliance.
-
Our consulting pharma services extend to RWD/RWE strategies that strengthen submissions, payer negotiations, and post-approval commitments.
Multidisciplinary Regulatory Expertise to Accelerate Success
Across every phase of the product lifecycle, Ergomed Consulting experts elevate your product viability–from shortened pathways to trial to regulatory agility and compliance, expedited global entry to sustained competitive edge. It’s what we do.
Ergomed Consulting Solutions
Ergomed Consulting delivers expert, customized regulatory consulting for clinical trials across the entire drug development lifecycle—from discovery and preclinical planning to regulatory submission and post-market management. With deep therapeutic knowledge, former regulators, and cross-functional CRO integration, we equip sponsors with the insight and support needed to move forward—confidently and compliantly—at every milestone.
Discovery & Preclinical Phase
In the early stages of drug development, companies often face significant challenges such as funding gaps, complex regulatory landscapes, and translational hurdles that can delay progress.
Clinical Research (Phases I–III)
Clinical development is often complicated by complex protocols, regulatory barriers, and fragmented market access strategies.
Market Application & Regulatory Review
During the market application and regulatory review phase, companies must navigate a complex regulatory framework, minimize the risk of submission delays, as well as disparate review and approval process.
Post-Market Safety & Lifecycle Management
Following market approval, evolving safety expectations, increasing demands for evidence generation, and lifecycle competition present ongoing challenges.
Strategic Pre-IND Consulting for Gene Therapy in Rare Leukemia
Early Stage Development in Rare Pediatric Oncology
Market Approval for a Novel Non-Hodgkin Lymphoma (NHL) Therapy
Post-Market Safety & Risk Management in Duchenne Muscular Dystrophy (DMD)
Team Member Spotlight:
Nan Shao, Executive Vice President of Ergomed Consulting
Our Executive Vice President of Ergomed Consulting, Nan Shao, brings over two decades of strategic and operational leadership in drug development. With a strong foundation as a trained statistician and extensive experience in both pharmaceutical and CRO settings, Nan has successfully led initiatives spanning the entire drug development lifecycle across diverse therapeutic areas.
Her expertise encompasses scientific rigor and operational excellence, empowering stakeholders through strategic use of data, optimized trial strategies, and patient-centric innovations. Nan is recognized for building collaborative, consultative partnerships that drive meaningful outcomes for clients and advance patient care.
In her role, Nan continues to shape the strategic direction of Ergomed Consulting by integrating data-driven insights, scientific innovation, and a steadfast commitment to improving healthcare outcomes.
Navigate the Complexities of the Entire Drug Development Path with Ergomed Consulting
At Ergomed Consulting, we simplify the complex with trusted regulatory consulting for clinical trials that spans the entire drug development lifecycle.
From early-stage planning to regulatory approval and post-market safety, our multidisciplinary team delivers integrated medical, scientific, statistical, and regulatory guidance tailored to your asset.
Whether you’re advancing a first-in-class therapy or refining a late-stage asset, our global regulatory affairs consulting helps you reduce risk, accelerate timelines, and bring safe, effective therapies to patients—worldwide.
Unparalleled Expertise,
Ergo, Flawless Execution
Our Complementary Services
See how Ergomed can support your clinical trial.
More Ergomed Services
Find out how Ergomed supports your clinical trial objectives.
Discover Our Latest Insights
Access Ergomed's resources for the latest in clinical trial trends and innovations.